Shot Block, FDA Rejects Regeneron Pharmaceuticals (NASDAQ: REGN) Twice Regeneron Pharmaceuticals faced a second rejection from the FDA for its lymphoma therapy, odronextamab, due to issues identified at a Catalent manufacturing...
The US government's plan to allow Medicare and Medicaid to cover Eli Lilly's weight loss drugs The US government’s plan to allow Medicare and Medicaid to cover Eli Lilly’s weight loss drugs starting in 2026 and 2027. This move includes Eli Lilly’s...
Fed up; Trump express his anger with Fed Chair Powell Early Friday morning President Donald Trump on Truth Social on Friday: Jerome “Too Late” Powell, a stubborn MORON, must substantially lower interest rates, NOW. IF HE CONTINUES TO REFUSE, THE BOARD SHOULD ASSUME...
